Category: CBD Stocks
TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for…
2 AI Stocks That Could Strengthen a Long-Term Portfolio
But with spending on AI growing rapidly, simply sticking with profitable, industry-leading companies can help you beat the average return…
CBD Life Sciences Inc. (CBDL) Announces Company Will Exhibit at the NECANN Cannabis Conference in Atlantic City, NJ
NECANN New Jersey attracts over 5,000 industry leaders, features more than 200 exhibitors, and is ranked the 3rd largest B2B…
Bull Of The Day: High Tide
High Tide (HITI) is a Zacks Rank #2 (Buy) that has an A for Value and an A for Growth….
Innocan Pharma Showcases Non-Opioid Pain Solution at PAINWeek 2025
Innocan Pharma Corporation is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the company has developed…
CENTR Brands Corp. Extends Debenture Maturity Amid Strategic Shifts
CENTR Brands ( ($TSE:CNTR) ) just unveiled an update. CENTR Brands Corp. has amended the terms of a previously issued…
Alabama CBD stores navigate new hemp product bans as President Trump eyes marijuana reclassification
Changes to federal and state regulations regarding marijuana, THC, and Delta 8 are proving challenging for some local CBD stores…
CV Sciences Sales Down 10 Percent
Operating income turned positive, mostly due to a $0.5 million one-time benefit, with actual operating income of $11,000, but adjusted…
2 Stocks Down More Than 90% That Still Aren’t Worth Buying
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182% for the…
Neural Therapeutics Acquires Stake in German CBD Retailer Hanf.com
An announcement from Neural Therapeutics Inc. ( ($TSE:NURL) ) is now available. Neural Therapeutics Inc. has completed the acquisition of…
Recent Comments